Integrated metabolic modeling, culturing and transcriptomics explains enhanced virulence of V. cholerae during co-infection with ETEC

Alyaa M. Abdel‐Haleem, Vaishnavi Ravikumar, Boyang Ji, Katsuhiko Mineta, Xin Gao, Jens Nielsen, Takashi Gojobori, Ivan Mijakovic̀bioRxiv 2020 · DOI

Abstract

Gene essentiality is traditionally studied in single-species environments, yet pathogens often exist within complex polymicrobial communities. This study investigates the co-infection of Vibrio cholerae and enterotoxigenic Escherichia coli (ETEC), two enteric pathogens that frequently co-occur in diarrheal patients. By integrating genome-scale metabolic models (GEMs), in vitro co-cultures, and dual RNAseq analysis, we demonstrate that ETEC enhances V. cholerae growth through metabolic cross-feeding. While V. cholerae thrives, it simultaneously suppresses ETEC growth via non-metabolic mechanisms. Crucially, we identify a core set of 47 essential genes that remain critical for V. cholerae survival regardless of the presence of ETEC, providing a roadmap for more robust drug targeting in polymicrobial contexts.

Introduction

In clinical settings, infections rarely occur in isolation. However, the majority of research into pathogen metabolism and drug discovery relies on single-species models. This creates a significant gap in our understanding of "gene essentiality"—the set of genes a bacterium requires to survive. If a co-infecting species provides a nutrient that a pathogen would otherwise have to synthesize, a drug targeting that synthesis pathway may become ineffective. This study addresses this gap by examining the interaction between Vibrio cholerae, the causative agent of cholera, and ETEC, a common co-pathogen that often leads to increased disease severity in dual-infected patients.

Methods and Modeling

To explore these interactions, researchers developed a high-quality metabolic reconstruction of V. cholerae V52 (an O37 serotype), designated iAM-Vc960. This model maps 2,172 reactions and 960 genes, providing a comprehensive view of the pathogen's metabolic capabilities.

The study utilized Flux Balance Analysis (FBA) to simulate community dynamics, combining the V. cholerae model with an existing ETEC model to predict metabolite exchange. These computational predictions were then validated through:

  • In Vitro Co-cultures: Competitive growth assays to observe population dynamics.
  • Dual RNAseq: Simultaneous transcriptomic sequencing of both species to identify gene expression shifts during co-infection.
  • Validation Benchmarks: Comparison against the Online GEne Essentiality (OGEE) database and existing experimental datasets.

Key Insights: Metabolic Cross-Feeding and Niche Expansion

The metabolic simulations revealed that V. cholerae possesses more restricted metabolic capabilities than E. coli. However, in a co-infection scenario, ETEC acts as a metabolic benefactor. ETEC provides "cross-fed" metabolites—such as putrescine, uridine, and various D-amino acids—that V. cholerae can utilize to bypass its own metabolic limitations.

This partnership significantly expands the pathogen's ecological niche. While V. cholerae could only grow in 51% of tested nutrient conditions in isolation, its growth capability expanded to 93% of conditions when ETEC was present. This expansion helps explain why dual infections are often more resilient and clinically severe.

The Dynamics of Suppression and Essentiality

Interestingly, the relationship is not mutually beneficial. While V. cholerae benefits from ETEC's metabolic byproducts, it suppresses ETEC growth. This suppression is likely mediated by non-metabolic factors, such as the Type VI Secretion System (T6SS), a molecular mechanism V. cholerae uses to inject toxins into neighboring bacterial cells.

The study also highlights that gene essentiality is context-dependent. For instance, certain ATP synthase subunits essential for V. cholerae in isolation became non-essential in the presence of ETEC, as the latter provided metabolic bypasses.

Identifying Robust Drug Targets

A primary goal of this research was to identify "conditionally-independent" genes—targets that remain essential for V. cholerae survival whether it is alone or in a polymicrobial environment. The integrated analysis identified 47 such genes, primarily involved in cofactor biosynthesis pathways (e.g., Coenzyme A and FAD). Because ETEC cannot "rescue" the pathogen from the loss of these specific functions, these 47 genes represent ideal targets for developing broad-spectrum treatments that remain effective during complex co-infections.

Conclusion

By combining computational modeling with experimental validation, this study demonstrates that the presence of other pathogens can fundamentally alter a bacterium's metabolic requirements and drug sensitivity. The identification of 47 robust essential genes provides a strategic advantage for future antibiotic development, ensuring that new treatments are effective in the complex, multi-species environments of the human gut.

Summary updated

Abstract

Abstract Gene essentiality is altered during polymicrobial infections. Nevertheless, most studies rely on single-species infections to assess pathogen gene essentiality. Here, we use genome-scale metabolic models to explore the effect of co-infection of the diarrheagenic pathogen Vibrio cholerae ( V. cholerae ) with another enteric pathogen, enterotoxigenic E. coli (ETEC). Model predictions showed that V. cholerae metabolic capabilities were increased due to ample cross-feeding opportunities enabled by ETEC. This is in line with increased severity of cholera symptoms known to occur in patients with dual-infections by the two pathogens. In vitro co-culture systems confirmed that V. cholerae growth is enhanced in co-cultures relative to single-cultures. Further, expression levels of several V. cholerae metabolic genes were significantly perturbed as shown by dual RNAseq analysis of its co-cultures with different ETEC strains. A decrease in ETEC growth was also observed, probably mediated by non-metabolic factors. Single gene essentiality analysis predicted conditionally-independent genes that are essential for the pathogen’s growth in both single- and co-infection scenarios. Our results reveal growth differences that are of relevance to drug targeting and efficiency in polymicrobial infections. Importance Most studies proposing new strategies to manage and treat infections have been largely focused on identifying druggable targets that can inhibit a pathogen’s growth when it is the single cause of infection. In vivo , however, infections can be caused by multiple species. This is important to take into account when attempting to develop or use current antibacterials since their efficacy can change significantly between single and co-infections. In this study, we used genome-scale metabolic models (GEMs) to interrogate the growth capabilities of Vibrio cholerae ( V. cholerae ) in single and co-infections with enterotoxigenic E. coli (ETEC), which co-occur in large fraction of diarrheagenic patients. Co-infection model predictions showed that V. cholerae growth capabilities are enhanced in presence of ETEC relative to V. cholerae single-infection, through cross-fed metabolites made available to V. cholerae by ETEC. In vitro , co-cultures of the two enteric pathogens further confirmed model predictions showing an increased growth of V. cholerae in co-culture relative to V. cholerae single-cultures while ETEC growth was suppressed. Dual RNAseq analysis of the co-cultures also confirmed that the transcriptome of V. cholerae is distinct during co-infection compared to single infection scenarios where processes related to metabolism were significantly perturbed. Further, in silico gene-knock out simulations uncovered discrepancies in gene essentiality for V. cholerae growth between single and co-infections. Integrative model-guided analysis thus identified druggable targets that would be critical for V. cholerae growth in both single and co-infections, thus designing inhibitors against those targets would provide a broader spectrum coverage against cholera infections.
BibTeX
@misc{abdelhaleem2020integrated,
  author = {Alyaa M. Abdel‐Haleem and Vaishnavi Ravikumar and Boyang Ji and Katsuhiko Mineta and Xin Gao and Jens Nielsen and Takashi Gojobori and Ivan Mijakovic̀},
  title = {{Integrated metabolic modeling, culturing and transcriptomics explains enhanced virulence of <i>V. cholerae</i> during co-infection with ETEC}},
  year = {2020},
  doi = {10.1101/2020.06.16.156158},
  howpublished = {bioRxiv},
}
Figure